$LFT
Lument Finance Trust, Inc.

2021 Q2 Form 10-Q Financial Statement

#000162828021016272 Filed on August 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $8.241M $8.480M
YoY Change -2.82% -17.58%
Cost Of Revenue $2.986M $3.700M
YoY Change -19.29% -40.71%
Gross Profit $5.254M $4.780M
YoY Change 9.93% 18.02%
Gross Profit Margin 63.76% 56.37%
Selling, General & Admin $1.792M $1.970M
YoY Change -9.06% -2.96%
% of Gross Profit 34.1% 41.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.840M $2.803M
YoY Change -34.37% 28.81%
Operating Profit $3.415M $1.977M
YoY Change 72.73% 5.5%
Interest Expense -$220.0K $3.696M
YoY Change -105.95% -40.79%
% of Operating Profit -6.44% 186.95%
Other Income/Expense, Net -$171.0K
YoY Change -37.59%
Pretax Income $1.626M $1.810M
YoY Change -10.15% 13.13%
Income Tax -$54.01K -$68.27K
% Of Pretax Income -3.32% -3.77%
Net Earnings $1.680M $1.879M
YoY Change -10.56% 34.77%
Net Earnings / Revenue 20.39% 22.15%
Basic Earnings Per Share $0.04
Diluted Earnings Per Share $0.04 $75.38K
COMMON SHARES
Basic Shares Outstanding 24.94M shares 24.94M shares
Diluted Shares Outstanding 24.94M shares 24.94M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.58M $8.900M
YoY Change 63.78% 23.61%
Cash & Equivalents $14.58M $8.857M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $96.85M $34.90M
YoY Change 177.5% 256.12%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $330.3M $7.400M
YoY Change 4362.98% -82.79%
Total Long-Term Assets $945.1M $620.8M
YoY Change 52.25% -4.14%
TOTAL ASSETS
Total Short-Term Assets $96.85M $34.90M
Total Long-Term Assets $945.1M $620.8M
Total Assets $1.042B $655.7M
YoY Change 58.92% -0.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $859.2K $600.0K
YoY Change 43.19% 50.0%
Accrued Expenses $666.3K $400.0K
YoY Change 66.57% -55.56%
Deferred Revenue
YoY Change
Short-Term Debt $826.1M $498.3M
YoY Change 65.78% -1.31%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $832.1M $502.1M
YoY Change 65.72% -1.39%
LONG-TERM LIABILITIES
Long-Term Debt $39.64M $39.50M
YoY Change 0.34% 0.77%
Other Long-Term Liabilities $900.0K $600.0K
YoY Change 50.0% 50.0%
Total Long-Term Liabilities $39.64M $39.50M
YoY Change 0.34% 0.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $832.1M $502.1M
Total Long-Term Liabilities $39.64M $39.50M
Total Liabilities $871.7M $541.6M
YoY Change 60.96% -1.26%
SHAREHOLDERS EQUITY
Retained Earnings $15.35M $5.841M
YoY Change 162.8% -702.27%
Common Stock $249.4K $249.4K
YoY Change 0.02% 5.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $170.1M $114.0M
YoY Change
Total Liabilities & Shareholders Equity $1.042B $655.7M
YoY Change 58.92% -0.26%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $1.680M $1.879M
YoY Change -10.56% 34.77%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $3.891M $2.780M
YoY Change 39.97% -1735.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$172.6M $5.740M
YoY Change -3107.78% -141.0%
Cash From Investing Activities -$172.6M $5.740M
YoY Change -3107.78% -141.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 469.7M -10.49M
YoY Change -4577.86% 486.03%
NET CHANGE
Cash From Operating Activities 3.891M 2.780M
Cash From Investing Activities -172.6M 5.740M
Cash From Financing Activities 469.7M -10.49M
Net Change In Cash 301.0M -1.970M
YoY Change -15377.78% -87.66%
FREE CASH FLOW
Cash From Operating Activities $3.891M $2.780M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001547546
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35845
dei Entity Registrant Name
EntityRegistrantName
LUMENT FINANCE TRUST, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-4966519
dei Entity Address Address Line1
EntityAddressAddressLine1
230 Park Avenue, 20th Floor, New York, New York
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10169
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
521-6323
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
2015617 USD
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24947883 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14576852 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11375960 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
330260821 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
57999396 USD
CY2021Q2 us-gaap Notes Receivable Net
NotesReceivableNet
611820226 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
547345334 USD
CY2021Q2 oaks Mortgage Service Rights At Fair Value
MortgageServiceRightsAtFairValue
678788 USD
CY2020Q4 oaks Mortgage Service Rights At Fair Value
MortgageServiceRightsAtFairValue
919678 USD
CY2021Q2 us-gaap Interest Receivable
InterestReceivable
2811728 USD
CY2021Q2 oaks Paydown Receivable
PaydownReceivable
79457686 USD
CY2020Q4 oaks Paydown Receivable
PaydownReceivable
0 USD
CY2021Q2 us-gaap Other Assets
OtherAssets
2356934 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
1833794 USD
CY2021Q2 us-gaap Assets
Assets
1041963035 USD
CY2020Q4 us-gaap Assets
Assets
621489779 USD
CY2021Q2 oaks Collateralized Loan Obligations
CollateralizedLoanObligations
826070345 USD
CY2020Q4 oaks Collateralized Loan Obligations
CollateralizedLoanObligations
463060090 USD
CY2021Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
39635259 USD
CY2020Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
39556198 USD
CY2021Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
666277 USD
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
432936 USD
CY2021Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
2967184 USD
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
3242640 USD
CY2021Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1527809 USD
CY2020Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1156340 USD
CY2021Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
859151 USD
CY2020Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
338423 USD
CY2021Q2 us-gaap Liabilities
Liabilities
871726025 USD
CY2020Q4 us-gaap Liabilities
Liabilities
507786627 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07875
CY2020 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07875
CY2021Q2 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
60000000 USD
CY2020Q4 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
60000000 USD
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2400000 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2400000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
57258435 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24947883 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24947883 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24943383 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24943383 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
249434 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
249389 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
233856352 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
233850271 USD
CY2021Q2 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
136575566 USD
CY2020Q4 us-gaap Accumulated Distributions In Excess Of Net Income
AccumulatedDistributionsInExcessOfNetIncome
131355978 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15348855 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10859970 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
170137510 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
113603652 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
99500 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
99500 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
170237010 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
113703152 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1041963035 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
621489779 USD
CY2021Q2 us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
8227979 USD
CY2020Q2 us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
8472153 USD
us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
15698096 USD
us-gaap Interest And Fee Income Loans Commercial Real Estate
InterestAndFeeIncomeLoansCommercialRealEstate
17637958 USD
CY2021Q2 us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
12778 USD
CY2020Q2 us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
7620 USD
us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
17078 USD
us-gaap Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper
InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper
35787 USD
CY2021Q2 oaks Interest Expense Collateralized Loan Obligations
InterestExpenseCollateralizedLoanObligations
2211947 USD
CY2020Q2 oaks Interest Expense Collateralized Loan Obligations
InterestExpenseCollateralizedLoanObligations
2915638 USD
oaks Interest Expense Collateralized Loan Obligations
InterestExpenseCollateralizedLoanObligations
4397189 USD
oaks Interest Expense Collateralized Loan Obligations
InterestExpenseCollateralizedLoanObligations
7153527 USD
CY2021Q2 oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
774363 USD
CY2020Q2 oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
780441 USD
oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
1546228 USD
oaks Interest Expense Secured Term Loan
InterestExpenseSecuredTermLoan
1560882 USD
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5254447 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4783694 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9771757 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8959336 USD
CY2021Q2 oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-220435 USD
CY2020Q2 oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-375176 USD
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-240890 USD
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-1252925 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1663926 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1663926 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q2 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
95766 USD
CY2020Q2 us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
204380 USD
us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
219922 USD
us-gaap Fees And Commissions Mortgage Banking And Servicing
FeesAndCommissionsMortgageBankingAndServicing
398527 USD
CY2021Q2 us-gaap Other Income
OtherIncome
0 USD
CY2020Q2 us-gaap Other Income
OtherIncome
0 USD
us-gaap Other Income
OtherIncome
0 USD
us-gaap Other Income
OtherIncome
2 USD
CY2021Q2 oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
-1788595 USD
CY2020Q2 oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
-170796 USD
oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
-1684894 USD
oaks Other Noninterest Income Loss
OtherNoninterestIncomeLoss
-854396 USD
CY2021Q2 oaks Management And Incentive Fees
ManagementAndIncentiveFees
725465 USD
CY2020Q2 oaks Management And Incentive Fees
ManagementAndIncentiveFees
590211 USD
oaks Management And Incentive Fees
ManagementAndIncentiveFees
1446464 USD
oaks Management And Incentive Fees
ManagementAndIncentiveFees
1175032 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
520013 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
978842 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1200327 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1744734 USD
CY2021Q2 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
496599 USD
CY2020Q2 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
346653 USD
oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
809053 USD
oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
807774 USD
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-48054 USD
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-833998 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-82807 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1134924 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
49491 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
52762 USD
us-gaap Share Based Compensation
ShareBasedCompensation
98626 USD
us-gaap Share Based Compensation
ShareBasedCompensation
106894 USD
CY2021Q2 us-gaap Noninterest Expense
NoninterestExpense
1839622 USD
CY2020Q2 us-gaap Noninterest Expense
NoninterestExpense
2802466 USD
us-gaap Noninterest Expense
NoninterestExpense
3637277 USD
us-gaap Noninterest Expense
NoninterestExpense
4969358 USD
CY2021Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
1626230 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
1810432 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
4449586 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
3135582 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54012 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-68271 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-39299 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-294792 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1680242 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1878703 USD
us-gaap Net Income Loss
NetIncomeLoss
4488885 USD
us-gaap Net Income Loss
NetIncomeLoss
4488885 USD
us-gaap Net Income Loss
NetIncomeLoss
3430374 USD
CY2021Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
725667 USD
CY2020Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
3750 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
729375 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7500 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
954575 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1874953 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3759510 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3422874 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
954575 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1874953 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3759510 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3422874 USD
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24944075 shares
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24939575 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24943731 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24925529 shares
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.04
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.15
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.14
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.09
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
113703152 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2021Q1 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
0 USD
CY2021Q1 oaks Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
0 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
2885 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
2808643 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
2244904 USD
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3708 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114266068 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11700 USD
CY2021Q2 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
0 USD
CY2021Q2 oaks Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
57258435 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
-8459 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1680242 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1680242 USD
CY2021Q2 us-gaap Dividends Common Stock
DividendsCommonStock
2245309 USD
CY2021Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
725667 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
170237010 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
108644712 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5747375 USD
CY2020Q1 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
13333 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
7882 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1551671 USD
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1870416 USD
CY2020Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3750 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114064141 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14985 USD
CY2020Q2 oaks Cost Of Issuing Of Common Stock Values
CostOfIssuingOfCommonStockValues
13333 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
-8473 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1878703 USD
CY2020Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1870754 USD
CY2020Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3750 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114061519 USD
us-gaap Net Income Loss
NetIncomeLoss
4488885 USD
us-gaap Net Income Loss
NetIncomeLoss
3430374 USD
oaks Accretion Of Discounts On Held For Investment Loans
AccretionOfDiscountsOnHeldForInvestmentLoans
3781 USD
oaks Accretion Of Discounts On Held For Investment Loans
AccretionOfDiscountsOnHeldForInvestmentLoans
0 USD
oaks Amortization Of Premiums On Held For Investment Loans
AmortizationOfPremiumsOnHeldForInvestmentLoans
78008 USD
oaks Amortization Of Premiums On Held For Investment Loans
AmortizationOfPremiumsOnHeldForInvestmentLoans
0 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-207767 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-570039 USD
oaks Amortization Of Offering Costs
AmortizationOfOfferingCosts
0 USD
oaks Amortization Of Offering Costs
AmortizationOfOfferingCosts
-26667 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
573113 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
512136 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1663926 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-240890 USD
oaks Unrealized Gain Loss On Mortgage Service Rights
UnrealizedGainLossOnMortgageServiceRights
-1252925 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
6126 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
14394 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
796111 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-169742 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-26667 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
523140 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
571307 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
233341 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-376506 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
371469 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-36481 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
520727 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
185432 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7061220 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5150748 USD
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
338386251 USD
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
41990011 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
273837132 USD
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
67402863 USD
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
79457686 USD
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
23781668 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-144006805 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1631184 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5747375 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
57258435 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
oaks Proceeds From Collateralized Loan Obligations
ProceedsFromCollateralizedLoanObligations
833750000 USD
oaks Proceeds From Collateralized Loan Obligations
ProceedsFromCollateralizedLoanObligations
0 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5487543 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3647328 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
7500 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
7500 USD
oaks Payment Of Collateralized Loan Obligations
PaymentOfCollateralizedLoanObligations
465316126 USD
oaks Payment Of Collateralized Loan Obligations
PaymentOfCollateralizedLoanObligations
8615358 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7789364 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
412407902 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6522811 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
275462317 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
259121 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69375356 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16011830 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
344837673 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16270951 USD
us-gaap Interest Paid Net
InterestPaidNet
4929197 USD
us-gaap Interest Paid Net
InterestPaidNet
8008740 USD
oaks Dividends Declared Not Yet Paid
DividendsDeclaredNotYetPaid
3164059 USD
oaks Dividends Declared Not Yet Paid
DividendsDeclaredNotYetPaid
1870754 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The financial statements have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires the Company to make a number of significant estimates. As of June 30, 2021, the novel coronavirus, or COVID-19, pandemic is ongoing. During 2020, the COVID-19 pandemic created disruption in global supply chains, increased rates of unemployment and adversely impacted many industries, including industries related to the collateral underlying certain of our loans. In 2021, the global economy has, with certain setbacks, begun reopening and wider distribution of vaccines will likely encourage greater economic activity. Nonetheless, the recovery could remain uneven, particularly given uncertainty with respect to the distribution and acceptance of the vaccines and their effectiveness with respect to new variants of the virus, including the Delta variant which is believed to be more contagious than previous variants of the virus. We believe the estimates and assumptions underlying our consolidated financial statements are reasonable and supportable based on the information available as of June 30, 2021, however uncertainty over the ultimate impact of COVID-19 on the global economy generally, and our business in particular, makes any estimates and assumptions as of June 30, 2021 inherently less certain than they would be absent the current and potential impacts of COVID-19. Actual results could differ from our estimates and the differences may be material.</span></div>
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14576852 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11375960 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
344837673 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69375356 USD
CY2021Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
0 USD
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24947883 shares
CY2021Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
0 USD
CY2021Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0 USD
CY2021Q2 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
1017419 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24947883 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24947883 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24947883 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24943383 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24943383 shares
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2400000 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2400000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.07875
CY2021Q2 oaks One Month Libor Rate
OneMonthLIBORRate
0.0008 USD
CY2020Q4 oaks One Month Libor Rate
OneMonthLIBORRate
0.0014 USD
CY2021Q2 oaks Weighted Average Libor Floor Rate
WeightedAverageLIBORFloorRate
0.0132 USD
CY2020Q4 oaks Weighted Average Libor Floor Rate
WeightedAverageLIBORFloorRate
0.0164 USD
oaks Accretion Of Discounts On Held For Investment Loans
AccretionOfDiscountsOnHeldForInvestmentLoans
3781 USD
oaks Amortization Of Premiums On Held For Investment Loans
AmortizationOfPremiumsOnHeldForInvestmentLoans
78008 USD
CY2021Q2 us-gaap Notes Receivable Net
NotesReceivableNet
611820226 USD
CY2021Q2 oaks Average Risk Rate
AverageRiskRate
2.6
CY2020Q4 oaks Average Risk Rate
AverageRiskRate
3.1
CY2021Q2 oaks Number Of Newly Formed Subsidiaries
NumberOfNewlyFormedSubsidiaries
2 subsidiary
CY2021Q2 oaks Variable Interest Entity Qualitative And Quantitative Information Equity Interest
VariableInterestEntityQualitativeAndQuantitativeInformationEquityInterest
96250000 USD
CY2021Q2 oaks Proceeds From Issuance Of Debt Securities Allocated To Acquire Additional Loan Obligations
ProceedsFromIssuanceOfDebtSecuritiesAllocatedToAcquireAdditionalLoanObligations
330300000 USD
CY2021Q2 oaks Period To Acquire Additional Loan Obligations From Closing Date
PeriodToAcquireAdditionalLoanObligationsFromClosingDate
P180D
CY2021Q2 oaks Collateralized Loan Obligation Leverage Ratio
CollateralizedLoanObligationLeverageRatio
0.83
CY2019Q1 oaks Collateralized Loan Obligation Unamortized Discount
CollateralizedLoanObligationUnamortizedDiscount
39200000 USD
CY2021Q2 oaks Collateralized Loan Obligation Deferred Financing Costs
CollateralizedLoanObligationDeferredFinancingCosts
614741 USD
CY2020Q4 oaks Collateralized Loan Obligation Deferred Financing Costs
CollateralizedLoanObligationDeferredFinancingCosts
693802 USD
CY2021Q2 us-gaap Secured Debt
SecuredDebt
40250000 USD
CY2021Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40250000 USD
CY2020Q4 us-gaap Secured Debt
SecuredDebt
40250000 USD
CY2020Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40250000 USD
CY2021Q2 us-gaap Secured Debt
SecuredDebt
40250000 USD
CY2021Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40250000 USD
CY2020Q4 us-gaap Secured Debt
SecuredDebt
40250000 USD
CY2020Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40250000 USD
CY2021Q2 oaks Number Of Licensed Sub Servicers
NumberOfLicensedSubServicers
2 numberOfMortgageSub-servicers
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
678788 USD
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
919678 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11375960 USD
CY2020Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
39556198 USD
CY2019 oaks Management Fee Percentage
ManagementFeePercentage
0.015
CY2019 oaks Quarterly Management Fee Percentage
QuarterlyManagementFeePercentage
0.00375
CY2021Q2 us-gaap Management Fee Expense
ManagementFeeExpense
725465 USD
CY2020Q2 us-gaap Management Fee Expense
ManagementFeeExpense
590211 USD
CY2021Q2 us-gaap Management Fee Payable
ManagementFeePayable
726000 USD
CY2020Q2 us-gaap Management Fee Payable
ManagementFeePayable
588000 USD
us-gaap Management Fee Expense
ManagementFeeExpense
1314232 USD
us-gaap Management Fee Expense
ManagementFeeExpense
1175032 USD
CY2021Q2 us-gaap Management Fee Payable
ManagementFeePayable
726000 USD
CY2020Q2 us-gaap Management Fee Payable
ManagementFeePayable
588000 USD
CY2020Q2 oaks Incentive Fees
IncentiveFees
0 USD
CY2021Q2 oaks Incentive Fees
IncentiveFees
0 USD
oaks Incentive Fees
IncentiveFees
132232 USD
oaks Incentive Fees
IncentiveFees
0 USD
CY2021Q2 oaks Incentive Fees Payable
IncentiveFeesPayable
132232 USD
CY2020Q2 oaks Incentive Fees Payable
IncentiveFeesPayable
0 USD
CY2021Q2 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
496599 USD
CY2020Q2 oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
346653 USD
CY2021Q2 oaks Reimbursable Costs Payable
ReimbursableCostsPayable
497000 USD
CY2020Q2 oaks Reimbursable Costs Payable
ReimbursableCostsPayable
367500 USD
CY2021Q2 oaks Exit Fee Waived Percentage Reduced
ExitFeeWaivedPercentageReduced
0.50
CY2021Q2 oaks Reimbursable Operating Expense Waived
ReimbursableOperatingExpenseWaived
46838 USD
CY2020Q2 oaks Reimbursable Operating Expense Waived
ReimbursableOperatingExpenseWaived
73549 USD
oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
809053 USD
oaks Reimbursable Operating Expense
ReimbursableOperatingExpense
807774 USD
CY2021Q2 oaks Reimbursable Costs Payable
ReimbursableCostsPayable
497000 USD
CY2020Q2 oaks Reimbursable Costs Payable
ReimbursableCostsPayable
367500 USD
CY2021Q2 oaks Exit Fee Waived Percentage Reduced
ExitFeeWaivedPercentageReduced
0.50
oaks Reimbursable Operating Expense Waived
ReimbursableOperatingExpenseWaived
175959 USD
oaks Reimbursable Operating Expense Waived
ReimbursableOperatingExpenseWaived
73549 USD
CY2021Q2 oaks Number Of Participation Interests Funded
NumberOfParticipationInterestsFunded
18 contract
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24947883 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24947883 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24943383 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24943383 shares
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
7500 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1680242 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1878703 USD
CY2021Q2 us-gaap Dividends Common Stock
DividendsCommonStock
2245309 USD
CY2020Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1870754 USD
CY2021Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
725667 USD
CY2020Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3750 USD
CY2021Q2 us-gaap Dividends
Dividends
2970976 USD
CY2020Q2 us-gaap Dividends
Dividends
1874504 USD
CY2021Q2 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
-1290734 USD
CY2020Q2 us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
4199 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24939575 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24935372 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4500 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4203 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24944075 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24939575 shares
us-gaap Net Income Loss
NetIncomeLoss
4488885 USD
us-gaap Net Income Loss
NetIncomeLoss
4488885 USD
us-gaap Net Income Loss
NetIncomeLoss
3430374 USD
us-gaap Dividends Common Stock
DividendsCommonStock
4490214 USD
us-gaap Dividends Common Stock
DividendsCommonStock
3741170 USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
729375 USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
7500 USD
us-gaap Dividends
Dividends
5219589 USD
us-gaap Dividends
Dividends
3748670 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24939231 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4352 shares
us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
-730704 USD
us-gaap Undistributed Earnings Loss Available To Common Shareholders Basic
UndistributedEarningsLossAvailableToCommonShareholdersBasic
-318296 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24939231 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24921177 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24921177 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4500 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4500 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4352 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24943731 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24943731 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24925529 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24925529 shares

Files In Submission

Name View Source Status
0001628280-21-016272-index-headers.html Edgar Link pending
0001628280-21-016272-index.html Edgar Link pending
0001628280-21-016272.txt Edgar Link pending
0001628280-21-016272-xbrl.zip Edgar Link pending
a20210630exhibit31-1.htm Edgar Link pending
a20210630exhibit31-2.htm Edgar Link pending
a20210630exhibit32-1.htm Edgar Link pending
a20210630exhibit32-2.htm Edgar Link pending
exhibit101.htm Edgar Link pending
exhibit102.htm Edgar Link pending
exhibit103.htm Edgar Link pending
exhibit104.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
oaks-20210630.htm Edgar Link pending
oaks-20210630.xsd Edgar Link pending
oaks-20210630_cal.xml Edgar Link unprocessable
oaks-20210630_def.xml Edgar Link unprocessable
oaks-20210630_g1.jpg Edgar Link pending
oaks-20210630_htm.xml Edgar Link completed
oaks-20210630_lab.xml Edgar Link unprocessable
oaks-20210630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending